3 research outputs found
A lncRNA-SWI/SNF complex crosstalk controls transcriptional activation at specific promoter regions
LncRNAs have been shown to be direct players in chromatin regulation, but little is known about their role at active genomic loci. We investigate the role of lncRNAs in gene activation by profiling the RNA interactome of SMARCB1-containing SWI/SNF complexes in proliferating and senescent conditions. The isolation of SMARCB1-associated transcripts, together with chromatin profiling, shows prevalent association to active regions where SMARCB1 differentially binds locally transcribed RNAs. We identify SWINGN, a lncRNA interacting with SMARCB1 exclusively in proliferating conditions, exerting a pro-oncogenic role in some tumor types. SWINGN is transcribed from an enhancer and modulates the activation of GAS6 oncogene as part of a topologically organized region, as well as a larger network of pro-oncogenic genes by favoring SMARCB1 binding. Our results indicate that SWINGN influences the ability of the SWI/SNF complexes to drive epigenetic activation of specific promoters, suggesting a SWI/SNF-RNA cooperation to achieve optimal transcriptional activation
A lncRNA-SWI/SNF complex crosstalk controls transcriptional activation at specific promoter regions
LncRNAs have been shown to be direct players in chromatin regulation, but little is known about their role at active genomic loci. We investigate the role of lncRNAs in gene activation by profiling the RNA interactome of SMARCB1-containing SWI/SNF complexes in proliferating and senescent conditions. The isolation of SMARCB1-associated transcripts, together with chromatin profiling, shows prevalent association to active regions where SMARCB1 differentially binds locally transcribed RNAs. We identify SWINGN, a lncRNA interacting with SMARCB1 exclusively in proliferating conditions, exerting a pro-oncogenic role in some tumor types. SWINGN is transcribed from an enhancer and modulates the activation of GAS6 oncogene as part of a topologically organized region, as well as a larger network of pro-oncogenic genes by favoring SMARCB1 binding. Our results indicate that SWINGN influences the ability of the SWI/SNF complexes to drive epigenetic activation of specific promoters, suggesting a SWI/SNF-RNA cooperation to achieve optimal transcriptional activation
Chromatin activation as a unifying principle underlying pathogenic mechanisms in multiple myeloma
Multiple myeloma (MM) is a plasma cell neoplasm associated with a broad variety of genetic lesions. In spite of this genetic
heterogeneity, MMs share a characteristic malignant phenotype whose underlying molecular basis remains poorly characterized.
In the present study, we examined plasma cells from MM using a multi-epigenomics approach and demonstrated
that, when compared to normal B cells, malignant plasma cells showed an extensive activation of regulatory elements, in
part affecting coregulated adjacent genes. Among target genes up-regulated by this process, we found members of the
NOTCH, NF-kB, MTOR signaling, and TP53 signaling pathways. Other activated genes included sets involved in osteoblast
differentiation and response to oxidative stress, all of which have been shown to be associated with the MM phenotype and
clinical behavior. We functionally characterized MM-specific active distant enhancers controlling the expression of thioredoxin
(TXN), a major regulator of cellular redox status and, in addition, identified PRDM5 as a novel essential gene for MM.
Collectively, our data indicate that aberrant chromatin activation is a unifying feature underlying the malignant plasma cell
phenotype